Obligation of User Fee Collections
The user fees collected are expended only for costs necessary to support the process for the review of medical device applications, as defined in MDUFMA. The allowable and excludable costs for the process for the review of medical device applications are defined in Appendix D. In FY 2009, FDA obligated $47,302,744 from medical device user fees. The following table provides a breakout of user fee obligations by expense categories during the past fiscal year.
FOOD AND DRUG ADMINISTRATION
FY 2009 MEDICAL DEVICE REVIEW OBLIGATIONS BY EXPENSE CATEGORY
AS OF SEPTEMBER 30, 2009
Expense Category FY 2009 Personnel Compensation and Benefits $31,601,700 Travel and Transportation $411,743 GSA Rent $2,056,920 Communications $221,797 Contract Services $10,094,444 Equipment and Supplies $2,792,848 Other (1) $123,292 Total Obligations $47,302,744
(1) Other includes expense categories like rent payments to others, printing & reproduction, and other miscellaneous expenses.
More information about the costs of the process for device review, as defined in MDUFMA, begins on page 7.